Kumar Raja, PhD
Brookline Capital Markets
Keay Nakae, CFA
Chardan
Albert Lowe, PhD
Craig-Hallum Capital Group LLC
Yatin Suneja
Guggenheim Securities, LLC
Emily Bodnar
H.C. Wainwright & Co., LLC
Thomas J. Smith
Leerink Partners
Leland Gershell, MD, PhD
Oppenheimer & Co., Inc.
Seema Sheoran, PhD
Rodman & Renshaw
Michael Yee
UBS
SAB Biotherapeutics is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding SAB Biotherapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of SAB Biotherapeutics or its management. SAB Biotherapeutics does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.